Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
59,964,750
-
Total 13F shares
-
54,065,958
-
Share change
-
-454,615
-
Total reported value
-
$812,370,471
-
Put/Call ratio
-
102%
-
Price per share
-
$15.02
-
Number of holders
-
180
-
Value change
-
-$4,927,701
-
Number of buys
-
94
-
Number of sells
-
79
Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q1 2021
As of 31 Mar 2021,
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) was held by
180 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,065,958 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, Palo Alto Investors LP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, MACQUARIE GROUP LTD, DIMENSIONAL FUND ADVISORS LP, LSV ASSET MANAGEMENT, and Epoch Investment Partners, Inc..
This page lists
180
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.